successively with n-hexane (3 l) and ethyl acetate (EtOAc, 4 l) to yield n-hexane-and EtOAc-soluble fractions (20 and 8 g, respectively). The EtOAc-soluble fraction, which significantly inhibited HNE, was subjected to chromatography on a silica gel column. Elution with a gradient solvent system consisting of CH 2 Cl 2 -MeOH (50:1-1:1) yielded four fractions A-C. Fraction A (1.1 g) was applied to a silica gel column and eluted using n-hexane-acetone (10:1), yielding compound 2 (25 mg). Fraction B (0.8 g) was applied to the same silica gel column and eluted using a hexane-acetone gradient solvent system (10:1-5:1), yielding compound 3 (8 mg). Chromatography of fraction C (1.8 g) on the silica gel column using a CH 2 Cl 2 -MeOH gradient solvent system (10:1-1:1) yielded four subfractions (C1-C4). Subfraction C2 (0.2 g) was further purified by preparative reverse phase-high-performance liquid chromatography on a YMCpack Pro C 18 (YMC, Tokyo, Japan) (250Â10 mm) column (UV detection at 254 nm) using MeOH-H 2 O (20:80, v/v) at a flow rate of 2.0 ml min À1 as the mobile phase. This procedure yielded compounds 1 (5 mg) and 4 (4 mg) with retention times (t R ) of 6. (Figure 1 ). On the basis of the above data, the structure of pleurone was established as 4H-1,3-dioxine-2, 4-dione (1).
Comparison of the physicochemical and spectral data for compounds 2, 3 and 4 with those in the literature identified these compounds as ergosterol (2), 10 (24E)-3b-hydroxycucurbita-5,24-diene-26-oic acid (3) 11 and nicotinic acid (4). 12 To the best of our knowledge, this is the first report of the constituents of P. eryngii var. ferulae.
The inhibitory activity of the isolated compounds 1-4 on HNE was evaluated according to a previously described procedure. 13 Briefly, 100-ml reactions containing 10 mM Tris-HCl buffer (pH 7.5), 1.4 mM MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide, 0.18 U HNE (EC 3.4.21.37, from Serva, Heidelberg, Germany), and various concentrations of sample were incubated in the wells of a 96-well plate for 2 h at 37 1C in the dark. Each reaction was stopped by the addition of 100 ml of soybean trypsin inhibitor (0.2 mg ml À1 ), and the absorbance at 405 nm was immediately measured using a microplate reader. Epigallocatechin gallate was used as a positive control. As shown in Table 1 , all of the tested compounds except nicotinic acid (4) moderately inhibited HNE. The IC 50 values for 1, 2, and 3 ranged from 49.4 to 61.5 mM; in contrast, the IC 50 value for the positive control, epigallocatechin gallate, was 8.8 ± 0.8 mM. Although pleurone exhibited a relatively low HNE-inhibitory activity compared with epigallocatechin gallate, it might be more useful as a new HNE inhibitor due to its relatively high water solubility and low MW.
To further characterize the HNE-inhibitory behavior of pleurone, kinetic studies were carried out in the same reaction medium in the presence of 0, 30 or 100 mM pleurone at substrate concentrations ranging from 0.25 to 1 mM. Reactions were started by the addition of diluted substrate and recorded over a time interval of 10 min. Estimations of the maximal velocity (V max ) and K m were made according to Eisenthal and Cornish-Bowden. 14 The kinetic data are shown as a Lineweaver-Burk plot in Figure 2 . The oxidation of HNE by pleurone followed Michaelis-Menten kinetics under the experimental conditions used. The intersection of the best-fit lines for the uninhibited enzyme and for the two different concentrations of pleurone occurs to the left of the 1/V 0 axis and below the 1/[S] axis on the Lineweaver-Burk plot, indicating that both K m and V max decreased with increasing pleurone concentration. Thus, the inhibitory mechanism of pleurone on HNE is a mixed-type, a combination of noncompetitive and uncompetitive inhibition against HNE.
Despite its name, HNE has broad substrate specificity and can cleave not only elastin but also other extracellular matrix proteins, such as collagen, fibronectin, laminin and proteoglycan. 15 Under normal physiological conditions, tissue repair after wounding requires the activity of elastase, which degrades foreign proteins within the extracellular matrix during phagocytosis. 13 Because the pharmacologic inhibition of HNE might prevent the loss of skin elasticity, thus preventing skin sagging during aging, efforts to discover potent inhibitors of HNE have increased considerably in the last several years. These efforts have focused on natural products as a rich source of potential HNE inhibitors. Our findings suggest that P. eryngii var. ferulae and its components might be beneficial for the prevention or treatment of skin aging. 
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